This event is part of a series of workshops covering various research themes central for SciLifeLab. The Drug Discovery and Development platform invites you to take part in the symposium “Clinical and Regulatory Perspective on Drug Development” June 12th in Uppsala. There will be ample time for discussion, as the aim is to stimulate collaborations.
|10:00 – 10:10||Welcome
Vendela Parrow, Dr Med Sci, In vitro and systems pharmacology, SciLifeLab Drug Discovery and Development Platform.
|10:10 – 10:50||Regulatory perspective on drug development from a Non-clinical assessor’s point of view
Per Garberg, Dr Med Sci, MPA Sweden
|10:50 – 11:30||Biologicals and biosimilars in the wind – what is new
Venke Skibeli, PhD, Legemiddelsverket (MPA Norway)
|11:40 – 13:00||Lunch in Navet
Posters from the DDD platform
|13:00 – 13:40||From the consultants case-book: Selected project issues in early clinical development
Anders Neil, Uppsala University and Parexel
|13:45 – 14:30||Clinical aspects on drug development in oncology
Peter Nygren, MD, Prof. Uppsala University and Akademiska sjukhuset.
|14:30 – 15:15||Coffee and Panel Discussion|
To register after June 1, please contact firstname.lastname@example.org
In your email, please state your position, if you are a SciLifeLab affiliate (Yes/No) and your allergies / dietary requirements.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.